Heterotaxy Syndrome: Defining Contemporary Disease Trends

被引:0
作者
Terence W. Prendiville
Leslie L. Barton
William R. Thompson
Doran L. Fink
Kathryn W. Holmes
机构
[1] Johns Hopkins Hospital,Division of Pediatric Cardiology
[2] Johns Hopkins Hospital,Division of Pediatric Infectious Diseases
[3] University of Arizona,Department of Pediatrics, College of Medicine
来源
Pediatric Cardiology | 2010年 / 31卷
关键词
Asplenia; Inferior vena cava; Malrotation; Polysplenia;
D O I
暂无
中图分类号
学科分类号
摘要
The purpose of this study was to define a population of visceral heterotaxy and to investigate the incidence of bacterial sepsis in the current era of universal pediatric pneumococcal immunization. Pediatric echocardiography and radiology databases, along with electronic medical records, were searched for patients followed-up since birth between 1999 and 2009 with either asplenia or polysplenia and cardiac anatomy consistent with heterotaxy syndrome. A total of 29 patients were identified. Seven patients (24%) had a total of 8 sepsis events, and 6 patients (86%) developed sepsis while taking appropriately prescribed antibiotic prophylaxis. Of the patients with sepsis, 5 had polysplenia and 2 had asplenia. Sixty-two percent of sepsis events were nosocomially acquired. No cases of pneumococcal sepsis occurred after the introduction of the conjugated pneumococcal vaccination to the pediatric vaccination schedule. Bacterial sepsis was associated with a 44% mortality rate. An unexpected finding in 3 patients with visceral heterotaxy, asplenia, and an interrupted inferior vena cava (IVC) as the only anomaly on echocardiography was associated intestinal malrotation. Children with visceral heterotaxy remain at significant risk of life-threatening bacterial infection. In addition, the finding of interrupted IVC on echocardiography should prompt screening for intestinal malrotation, even in the absence of additional structural heart disease.
引用
收藏
页码:1052 / 1058
页数:6
相关论文
共 163 条
[1]  
Abou Elella R(2010)Impact of bloodstream infection on the outcome of children undergoing cardiac surgery Pediatr Cardiol 31 483-489
[2]  
Najm HK(2009)Improved current era outcomes in patients with heterotaxy syndromes Eur J Cardiothorac Surg 35 871-877
[3]  
Balkhy H(2001)Improving outcomes of the Fontan operation in children with atrial isomerism and heterotaxy syndromes Ann Thorac Surg 72 1636-16640
[4]  
Bullard L(2010)Major infection after pediatric cardiac surgery: a risk estimation model Ann Thorac Surg 89 843-850
[5]  
Kabbani MS(2006)Early and late results of the modified Fontan operation for heterotaxy syndrome: 30 years of experience in 142 patients J Am Coll Cardiol 48 2301-2305
[6]  
Anagnostopoulos PV(1981)Congenital asplenia: immunologic assessment and a clinical review of eight surviving patients Pediatrics 67 548-551
[7]  
Pearl JM(1992)Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine Chest 101 1644-1655
[8]  
Octave C(2005)Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project Am J Surg 189 395-404
[9]  
Cohen M(2007)Development and function of the mammalian spleen Bioessays 29 166-177
[10]  
Gruessner A(2007)Heterotaxia, congenital heart disease, and primary ciliary dyskinesia Circulation 115 2793-2795